{
    "SPADE_UN_00521": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_00521",
            "Peptide Name": "W9F,T14A (mutant of Def-DAA defensin)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "ATCDLASKFNWNHALCAAHCIARRYRGGYCNSKAVCVCR",
            "Sequence Length": 39,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+"
            ],
            "Target Organism": "Gram-positive bacteria:Staphylococcus aureus strain 21 (IC90=2-4 µg/mL), Staphylococcus aureus strain 4 (IC90=2-4 µg/mL).",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "Not included yet",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not included yet",
            "N-terminal Modification": "Not included yet",
            "C-terminal Modification": "Not included yet",
            "Stereochemistry": "Not included yet",
            "Structure Description": "Not found",
            "Formula": "C183H287N61O50S6",
            "Mass": 4334.01,
            "PI": 9.15,
            "Net Charge": 7,
            "Hydrophobicity": -0.05,
            "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour",
            "Function": "Mutant of Def-DAA defensin (W9F,T14A) is active against sensitive and resistant strains of S. aureus. All the mutants are less toxic than Def-DAA except one (W11V) but are more toxic than Def-AcAA.",
            "Literature": [
                {
                    "Title": "Rational design of peptides active against the gram positive bacteria Staphylococcus aureus.",
                    "Pubmed ID": "18214975",
                    "Reference": "Proteins. 2008 Jul;72(1)229-239.",
                    "Author": "Landon C, Barbault F, Legrain M, Guenneugues M, Vovelle F.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=18214975"
                }
            ],
            "Frequent Amino Acids": "ACR",
            "Absent Amino Acids": "EMOPQU",
            "Basic Residues": 8,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 16,
            "Polar Residues": 31,
            "Positive Residues": 8,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_00517",
                    "Similarity": 0.9743589743589743,
                    "Sequence": "ATCDLASKFNWNHTLCAAHCIARRYRGGYCNSKAVCVCR"
                },
                {
                    "SPADE_ID": "SPADE_UN_00522",
                    "Similarity": 0.9743589743589743,
                    "Sequence": "ATCDLASIFNWNHALCAAHCIARRYRGGYCNSKAVCVCR"
                },
                {
                    "SPADE_ID": "SPADE_N_07473",
                    "Similarity": 0.9655172413793104,
                    "Sequence": "WNHTLCAAHCIARRYRGGYCNSKAVCVCR"
                }
            ]
        }
    }
}